In an 83‑year‑old woman with serum bicarbonate 33 mmol/L, AST 36 U/L, ALT 36 U/L, hematocrit 46.3 %, and mean platelet volume 12.8 fL, what is the clinical significance and recommended management?

Clinical Significance and Management of Laboratory Abnormalities in an 83-Year-Old Woman

Serum Bicarbonate (CO₂) 33 mmol/L

The mildly elevated serum bicarbonate of 33 mmol/L (normal 23–30 mmol/L) represents a metabolic alkalosis that warrants investigation for underlying causes but does not require immediate intervention in an asymptomatic patient. 1

Clinical Context

• The normal range for serum total CO₂ (bicarbonate) at sea level is 23–30 mmol/L, not the overly wide 20–32 mmol/L range reported by many laboratories 1
• A value of 33 mmol/L represents mild metabolic alkalosis, which in elderly patients is most commonly caused by:
  • Diuretic use (thiazide or loop diuretics causing contraction alkalosis)
  • Volume depletion/dehydration (plasma volume contraction)
  • Chronic respiratory acidosis with compensation (COPD with renal bicarbonate retention)
  • Vomiting or nasogastric suction (loss of gastric acid)

Recommended Evaluation

• Assess hydration status and review all medications, particularly diuretics 1
• Check serum electrolytes (potassium, chloride) to identify contraction alkalosis pattern (low chloride, low potassium) 1
• If chronic lung disease is suspected, obtain arterial blood gas to distinguish primary metabolic alkalosis from compensated respiratory acidosis 1
• No specific treatment is needed unless bicarbonate exceeds 35 mmol/L or symptoms develop 1

---

Liver Enzymes: AST 36 U/L and ALT 36 U/L

These minimally elevated transaminases (AST and ALT both 36 U/L, just above upper limits of normal) are nonspecific and do not indicate clinically significant liver disease in an asymptomatic elderly patient.

Clinical Significance

• AST 36 U/L (normal 10–35 U/L) and ALT 36 U/L (normal 6–29 U/L) represent grade 1 elevation (< 3× upper limit of normal) 2
• The AST/ALT ratio is 1.0, which does not suggest alcohol-related liver disease (typically AST/ALT > 1.5–2.0) or advanced fibrosis 2
• In alcoholic hepatitis, AST is typically > 50 U/L and rarely exceeds 300 U/L, with AST/ALT ratio > 1.5–2.0; this pattern is absent here 2

Recommended Management

• No immediate intervention is required for this degree of transaminase elevation in an asymptomatic patient 2
• Consider repeat testing in 3–6 months to assess for progression 2
• If values remain persistently elevated or increase, evaluate for:
  • Medication-induced liver injury (review all medications, supplements, herbal products)
  • Non-alcoholic fatty liver disease (assess metabolic syndrome components)
  • Alcohol use (obtain detailed history; consider EtG testing if suspected) 2
  • Viral hepatitis (hepatitis B and C serology if risk factors present)
• Liver biopsy is not indicated at this level of elevation unless there is diagnostic uncertainty or evidence of progressive disease 2

---

Hematocrit 46.3%

The hematocrit of 46.3% is at the upper limit of normal for an elderly woman and warrants confirmation with repeat testing and hemoglobin measurement to exclude true erythrocytosis.

Diagnostic Thresholds

• Normal hematocrit for post-menopausal women is 41 ± 5% (range approximately 36–46%) 3
• True erythrocytosis in women is defined as hematocrit > 48–49% or hemoglobin > 16.5 g/dL 3, 4
• This patient's value of 46.3% is borderline elevated but does not meet criteria for erythrocytosis 3

Recommended Evaluation

• Repeat complete blood count with hemoglobin measurement to confirm the finding, as a single measurement is unreliable 3
• Hemoglobin is more accurate than hematocrit for assessing red cell abnormalities because hematocrit can falsely increase by 2–4% with sample storage, while hemoglobin remains stable 3
• Assess hydration status to exclude relative polycythemia from dehydration or diuretic use 4
• If hematocrit remains elevated on repeat testing (> 48%) or hemoglobin > 16.5 g/dL, proceed with:
  • Serum ferritin and transferrin saturation (to assess iron status) 3
  • JAK2 mutation testing (to evaluate for polycythemia vera) 3, 4
  • Evaluation for secondary causes: smoking history, sleep study if obstructive sleep apnea suspected, pulmonary function tests if COPD suspected 3, 4

Management Principles

• Therapeutic phlebotomy is NOT indicated at this hematocrit level; it is only indicated when hemoglobin > 20 g/dL and hematocrit > 65% with symptoms of hyperviscosity 3
• Avoid repeated routine phlebotomies, as they cause iron depletion, decreased oxygen-carrying capacity, and paradoxically increase stroke risk 3
• For borderline values, serial monitoring every 6–12 months is appropriate 3

---

Mean Platelet Volume (MPV) 12.8 fL

The elevated MPV of 12.8 fL (normal range typically 7.5–11.5 fL) reflects increased platelet activation and is associated with cardiovascular risk factors, but does not require specific treatment in isolation.

Clinical Significance

• MPV correlates with platelet activation and has emerged as a marker of cardiovascular disease risk 5
• Elevated MPV is independently associated with:
  • Female gender 5
  • Diabetes mellitus 5
  • Metabolic syndrome 5
  • Hypertension and prehypertension 5
  • Elevated serum triglycerides 5
• MPV has a significant inverse correlation with platelet count and hematocrit 5

Recommended Management

• No specific treatment is directed at MPV itself; management focuses on underlying cardiovascular risk factors 5
• Screen for and optimize control of:
  • Blood pressure (target < 130/80 mmHg in elderly with comorbidities) 6
  • Diabetes (if present, target HbA1c based on individualized goals)
  • Lipid profile (assess for dyslipidemia)
  • Metabolic syndrome components 5
• Consider low-dose aspirin (81–100 mg daily) for cardiovascular risk reduction if other risk factors are present and bleeding risk is acceptable 3

---

Integrated Assessment and Common Pitfalls

Key Clinical Considerations

• The combination of borderline elevated hematocrit (46.3%) and elevated MPV (12.8 fL) shows an inverse relationship consistent with published data 5
• The mild metabolic alkalosis (CO₂ 33 mmol/L) may reflect chronic diuretic use, which could also contribute to relative polycythemia through plasma volume contraction 4, 1
• The minimally elevated transaminases are nonspecific and do not indicate significant liver pathology at this level 2

Critical Pitfalls to Avoid

• Do not use the overly wide laboratory reference range of 20–32 mmol/L for serum bicarbonate; the correct range is 23–30 mmol/L 1
• Do not perform therapeutic phlebotomy for hematocrit < 65% without documented hyperviscosity symptoms 3
• Do not overlook coexisting iron deficiency in patients with borderline erythrocytosis, as it can mimic hyperviscosity but requires iron supplementation, not phlebotomy 3
• Do not assume anemia is normal in elderly patients; stable hemoglobin levels are expected in elderly women 3

Recommended Follow-Up

• Repeat complete blood count with hemoglobin in 2–4 weeks to confirm hematocrit stability 3
• Repeat liver enzymes in 3–6 months if persistently elevated 2
• Assess and optimize cardiovascular risk factors given elevated MPV 5
• Review medication list for diuretics or other agents that may contribute to metabolic alkalosis 1